Santarus 8-K 2005
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
(d) On March 17, 2005, Santarus' board of directors voted to increase the size of the board from seven to eight members. In addition, Ted W. Love, M.D. was appointed by Santarus’ board of directors to serve as a Class III director to fill the vacancy created by such increase. This appointment by the board of directors was based on the recommendation of its nominating/corporate governance committee. Dr. Love was recommended to the nominating/corporate governance committee by members of Santarus’ board of directors, and has been determined by Santarus’ board of directors to be independent, as independence is currently defined in Rule 4200(a)(15) of the Nasdaq listing standards. Dr. Love was also appointed to the nominating/corporate governance committee.
Item 9.01. Financial Statements and Exhibits.
99.1 -- Press Release, dated March 18, 2005
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.